We found high-grade tumors (grade 3) had statistically significantly lower IQGAP3 expression compared with grade 1 and 2 tumors (Figure 2A), while no difference in expression was observed among cancer stages (Figure 2B) and nodal metastasis status (Figure 2C). This evidence concerns the gene IQGAP3 and cancer.